Status:
COMPLETED
Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Cardiovascular Disease
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-75 years
Brief Summary
The primary objective is to establish the safety of the CO-rebreathing method for measuring total blood and plasma volume in CAD patients. The working hypothesis is that the CO-rebreathing method is s...
Eligibility Criteria
Inclusion
- Stable coronary artery disease
- Stable COPD
- Optimal medication
Exclusion
- Unstable disease
- co-morbidities
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01470274
Start Date
November 1 2011
End Date
February 1 2012
Last Update
July 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwegian University of Science and Technology
Trondheim, Norway, 7489